Disorder strength measured by quantitative phase imaging as intrinsic cancer marker in fixed tissue biopsies.
Where this comes from
- Record sourced from PubMed, PMID 29561905.
- Also identified by DOI 10.1371/journal.pone.0194320 and PMC identifier 5862460.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tissue refractive index provides important information about morphology at the nanoscale. Since the malignant transformation involves both intra- and inter-cellular changes in the refractive index map, the tissue disorder measurement can be used to extract important diagnosis information. Quantitative phase imaging (QPI) provides a practical means of extracting this information as it maps the optical path-length difference (OPD) across a tissue sample with sub-wavelength sensitivity. In this work, we employ QPI to compare the tissue disorder strength between benign and malignant breast tissue histology samples. Our results show that disease progression is marked by a significant increase in the disorder strength. Since our imaging system can be added as an upgrading module to an existing microscope, we anticipate that it can be integrated easily in the pathology work flow.
Medical subject headings
- Biomarkers
- Breast Neoplasms
- Microscopy